Literature DB >> 30765477

SDF1α-induced chemotaxis of JAK2-V617F-positive cells is dependent on Bruton tyrosine kinase and its downstream targets PI3K/AKT, PLCγ1 and RhoA.

Subbaiah Chary Nimmagadda1,2,3, Stephanie Frey1,2, Peter Müller1,2, Denise Wolleschak1,2, Sönke Weinert4, Ulrich Keller3,5,6, Bärbel Edelmann1,2, Thomas Fischer7,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30765477      PMCID： PMC6601073          DOI： 10.3324/haematol.2018.201921

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  21 in total

1.  Epo-induced erythroid maturation is dependent on Plcγ1 signaling.

Authors:  T M Schnöder; P Arreba-Tutusaus; I Griehl; L Bullinger; M Buschbeck; S W Lane; K Döhner; C Plass; D B Lipka; F H Heidel; T Fischer
Journal:  Cell Death Differ       Date:  2014-11-14       Impact factor: 15.828

Review 2.  Genetic and epigenetic complexity in myeloproliferative neoplasms.

Authors:  Nicholas C P Cross
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

3.  Rho GTPases and their role in organizing the actin cytoskeleton.

Authors:  Soon-Tuck Sit; Ed Manser
Journal:  J Cell Sci       Date:  2011-03-01       Impact factor: 5.285

4.  RhoA and RhoC are involved in stromal cell-derived factor-1-induced cell migration by regulating F-actin redistribution and assembly.

Authors:  Jixian Luo; Dingyun Li; Dan Wei; Xiaoguang Wang; Lan Wang; Xianlu Zeng
Journal:  Mol Cell Biochem       Date:  2017-05-23       Impact factor: 3.396

5.  Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.

Authors:  Srdan Verstovsek; Hagop Kantarjian; Ruben A Mesa; Animesh D Pardanani; Jorge Cortes-Franco; Deborah A Thomas; Zeev Estrov; Jordan S Fridman; Edward C Bradley; Susan Erickson-Viitanen; Kris Vaddi; Richard Levy; Ayalew Tefferi
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

6.  C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients.

Authors:  Xiaoli Wang; Sool Yeon Cho; Cing Siang Hu; Daniel Chen; John Roboz; Ronald Hoffman
Journal:  Exp Hematol       Date:  2014-11-08       Impact factor: 3.084

7.  Bruton's tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing.

Authors:  David J J de Gorter; Esther A Beuling; Rogier Kersseboom; Sabine Middendorp; Janine M van Gils; Rudolf W Hendriks; Steven T Pals; Marcel Spaargaren
Journal:  Immunity       Date:  2007-01       Impact factor: 31.745

8.  Proteasome-dependent autoregulation of Bruton tyrosine kinase (Btk) promoter via NF-kappaB.

Authors:  Liang Yu; Abdalla J Mohamed; Oscar E Simonson; Leonardo Vargas; K Emelie M Blomberg; Bo Björkstrand; H Jose Arteaga; Beston F Nore; C I Edvard Smith
Journal:  Blood       Date:  2008-02-21       Impact factor: 22.113

9.  Tec/Bmx non-receptor tyrosine kinases are involved in regulation of Rho and serum response factor by Galpha12/13.

Authors:  J Mao; W Xie; H Yuan; M I Simon; H Mano; D Wu
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

10.  Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia.

Authors:  Stuart A Rushworth; Megan Y Murray; Lyubov Zaitseva; Kristian M Bowles; David J MacEwan
Journal:  Blood       Date:  2013-12-04       Impact factor: 22.113
View more
  4 in total

Review 1.  Bone marrow niches in haematological malignancies.

Authors:  Simón Méndez-Ferrer; Dominique Bonnet; David P Steensma; Robert P Hasserjian; Irene M Ghobrial; John G Gribben; Michael Andreeff; Daniela S Krause
Journal:  Nat Rev Cancer       Date:  2020-02-28       Impact factor: 60.716

Review 2.  Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology.

Authors:  Daniel Royston; Adam J Mead; Bethan Psaila
Journal:  Hematol Oncol Clin North Am       Date:  2021-04       Impact factor: 3.722

Review 3.  Understanding Aberrant Signaling to Elude Therapy Escape Mechanisms in Myeloproliferative Neoplasms.

Authors:  Maria Teresa Bochicchio; Valeria Di Battista; Pietro Poggio; Giovanna Carrà; Alessandro Morotti; Mara Brancaccio; Alessandro Lucchesi
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

4.  Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F-induced disease.

Authors:  Peter Müller; Conny K Baldauf; Tobias R Haage; Ana M Waldleben; Fabian Richter; Klaus Pfizenmaier; Thomas Fischer
Journal:  Blood Adv       Date:  2021-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.